Search
-
News
Learn about the role of radiation therapy in protecting women from breast cancer recurrence after breast-conserving surgery.
… Wednesday, June 3, 2020 Summary Radiation therapy given after breast-conserving surgery ( lumpectomy ) has proven effective at preventing the cancer from coming back. Learn more about different radiation therapy approaches for women with breast cancer and how to decide what is best for you. Women with
-
News
In a large-scale genomic analysis of the most common and aggressive type of ovarian cancer, researchers from Memorial Sloan Kettering and other centers identified genetic mutations and pathways that set the disease apart from other types of ovarian cancer and other solid tumors.
… Saturday, October 1, 2011 Summary In a large-scale genomic analysis of the most common and aggressive type of ovarian cancer, researchers from Memorial Sloan Kettering and other centers identified genetic mutations and pathways that set the disease apart from other types of ovarian cancer and other solid
-
News
While BRCA genes garner most of the public's attention, they're not the only cancer-predisposition genes doctors test for.
… Friday, October 18, 2019 Summary The science of clinical genetics is helping doctors understand more about the genes that increase a person’s risk of cancer, and which ones warrant genetic testing. When it comes to genes that predispose to cancer, most people have heard of BRCA1 and BRCA2 . Inherited
-
News
Increased breast density, but not BMI, is an additional risk factor for breast cancer in women with lobular carcinoma in situ (LCIS).
… Thursday, January 30, 2020 Increased breast density was an additional risk factor for breast cancer in women with lobular carcinoma in situ (LCIS). However, body mass index (BMI) was not, according to our retrospective study published recently in the Annals of Surgical Oncology . Among a group of 1,222
-
News
Read up on the latest developments in several important areas of cancer research emerging from the 2019 American Association for Cancer Research annual meeting.
… Sunday, March 31, 2019 Summary Memorial Sloan Kettering researchers are featured in more than 150 abstracts and events at the 2019 American Association for Cancer Research annual meeting in Atlanta. Their scientific contributions are helping advance understanding of all aspects of cancer. Here’s a round-up
-
News
Learn about Louis Voigt, a critical care medicine specialist who is Chair of MSK's Ethics Committee.
… Thursday, November 29, 2018 Summary Critical care medicine specialist Louis Voigt tells us about his background and philosophy of care, and explains the role of the Ethics Committee at MSK . How did you choose your specialty? Critical care came quite naturally to me both intellectually and emotionally
-
News
Dr. Andy Minn, the inaugural chair of MSK's Immuno-Oncology Program, discusses his vision for the program and what it means for patients.
… Wednesday, October 15, 2025 A revolution is underway in oncology, and in medicine more broadly. Immunotherapies are marshalling the power of the human immune system against cancer to augment or even sometimes replace traditional treatments — and they are starting to make inroads against autoimmune diseases
-
News
… Monday, May 23, 2022 You sometimes hear the steady beat of the drum before you see the boat. An imposing figure then comes into view, slicing through the water. It’s a multicolor 40-foot canoe. Finally, you hear the paddlers’ yells of encouragement: “Come on, faster. We can do this!” Welcome to dragon
-
News
A recent study from MSK investigators found that most patients who received genetic counseling by telemedicine during the early months of the pandemic reported being highly satisfied with the care they received.
… Wednesday, December 15, 2021 Sometimes a physical exam is a critical part of a healthcare visit. But patients are learning that for many medical appointments, a telemedicine visit can be just as valuable. Some people even prefer telemedicine, because they find speaking with a healthcare provider from
-
News
Memorial Sloan Kettering launched the Marie-Josée and Henry R. Kravis Center for Molecular Oncology, an ambitious initiative to improve cancer care and research through genomic analysis.
… Tuesday, May 20, 2014 New Marie-Josée and Henry R. Kravis Center for Molecular Oncology Aims to Analyze 10,000 Patient Tumors in Its First Year Memorial Sloan Kettering Cancer Center (MSK) today launched an ambitious initiative to improve cancer care and research through genomic analysis. The new program